Syros Pharmaceuticals, Inc.

SYRS

SYRSSyros Pharmaceuticals, Inc. US flag

Other OTC

0.00

USD

+0.00

- -

5,366.00Market Cap

Income Statement (USD)

API Chat

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Sales/Revenue/Turnover	- -	- -	- -	1	2	2	15	23	15	10
+ Sales & Services Revenue	- -	- -	- -	1	2	2	15	23	15	10
- Cost of Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Operating Income	- -	- -	- -	-1	-2	-2	-15	-23	-15	-10
- Operating Expenses	13	30	48	56	66	80	97	123	141	136
+ Selling, General & Admin	3	6	10	14	16	21	21	23	29	28
+ Research & Development	11	24	38	42	50	58	76	100	112	108
+ Other Operating Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income (Loss)	-13	-30	-48	-55	-64	-78	-82	-99	-126	-126
- Non-Operating (Income) Loss	- -	- -	- -	-1	-2	-2	2	-13	-32	38
+ Interest Expense, Net	- -	- -	- -	- -	-2	-2	1	4	2	-2
+ Interest Expense	- -	- -	- -	- -	- -	- -	2	4	4	5
- Interest Income	- -	- -	- -	- -	2	2	- -	- -	2	7
+ Other Non-Op (Income) Loss	- -	- -	- -	-1	- -	- -	- -	-17	-34	40
Pretax Income	-13	-30	-48	-54	-62	-75	-84	-87	-95	-165
- Income Tax Expense (Benefit)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	-13	-30	-48	-54	-62	-75	-84	-87	-95	-165
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) Incl. MI	-13	-30	-48	-54	-62	-75	-84	-87	-95	-165
- Minority Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income, GAAP	-13	-30	-48	-54	-62	-75	-84	-87	-95	-165
- Preferred Dividends	2	5	4	- -	- -	- -	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-16	-35	-51	-54	-62	-75	-84	-87	-95	-165
EBIT	-13	-30	-48	-55	-64	-78	-82	-99	-126	-126
EBITDA	-13	-29	-47	-53	-63	-75	-79	-96	-124	-124
EBITDA Margin (%)	- -	-9,217.03	-14,728.71	-4,828.25	-3,058.15	-3,785.02	-525.16	-410.43	-831.03	-1,250.47
EBITA	-13	-30	-48	-55	-64	-78	-82	-99	-126	-126
Gross Margin (%)	- -	100	100	100	100	100	100	100	100	100
Operating Margin (%)	- -	-9,406.94	-15,130.28	-4,966.94	-3,136.39	-3,922.35	-545.27	-423.28	-849.21	-1,273.14
Profit Margin (%)	- -	-9,406.31	-15,060.88	-4,905.54	-3,038	-3,806.16	-556.8	-368.52	-636.12	-1,656.34
Sales per Employee	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Depreciation Expense	- -	1	1	2	2	3	3	3	3	2
Basic Weighted Avg Shares	- -	- -	1	3	3	4	5	6	13	28
Basic EPS, GAAP	-63.19	-140.38	-40.5	-21.26	-19.07	-18.76	-18.25	-13.84	-7.49	-5.81
Basic EPS from Cont Ops	-54.25	-120.45	-37.6	-21.26	-19.07	-18.76	-18.25	-13.84	-7.49	-5.81
Diluted Weighted Avg Shares	- -	- -	1	3	3	4	5	6	13	28
Diluted EPS, GAAP	-63.19	-140.38	-40.5	-21.26	-19.07	-18.76	-18.25	-13.84	-7.49	-5.81
Diluted EPS from Cont Ops	-54.25	-120.45	-37.6	-21.26	-19.07	-18.76	-18.25	-13.84	-7.49	-5.81

Balance Sheet (USD)

API Chat

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Total Current Assets	61	36	86	73	102	115	179	137	211	145
+ Cash, Cash Equivalents & STI	60	36	84	72	100	91	174	130	202	140
+ Cash & Cash Equivalents	60	36	59	32	50	41	174	92	167	140
+ ST Investments	- -	- -	25	40	50	50	- -	38	35	- -
+ Accounts & Notes Receiv	- -	- -	1	- -	- -	20	2	3	2	- -
+ Accounts Receivable, Net	- -	- -	1	- -	- -	20	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -	- -	- -	2	3	2	- -
+ Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other ST Assets	- -	1	1	1	2	3	2	3	7	5
+ Misc ST Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	1	7	6	5	5	35	35	46	33	23
+ Property, Plant & Equip, Net	1	5	5	4	4	32	30	27	25	19
+ Property, Plant & Equip	1	6	7	8	9	36	37	37	37	27
- Accumulated Depreciation	- -	1	2	4	5	4	7	10	13	8
+ LT Investments & Receivables	- -	- -	- -	- -	- -	- -	- -	13	- -	- -
+ LT Investments	- -	- -	- -	- -	- -	- -	- -	13	- -	- -
+ LT Receivables	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other LT Assets	- -	2	1	1	1	4	5	6	8	4
+ Total Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	2	1	1	1	4	5	6	8	4
Total Assets	61	44	91	78	107	150	213	183	244	168
+ Payables & Accruals	1	7	7	10	14	12	9	13	16	21
+ Accounts Payable	1	5	2	2	3	6	4	4	6	12
+ Accrued Taxes	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Payables & Accruals	- -	2	4	7	11	6	5	9	9	9
+ ST Debt	- -	- -	- -	- -	- -	1	2	2	2	9
+ ST Borrowings	- -	- -	- -	- -	- -	- -	- -	- -	- -	7
+ ST Finance Leases	- -	- -	- -	- -	- -	1	2	2	2	2
+ Other ST Liabilities	- -	1	3	3	5	10	18	17	13	7
+ Deferred Revenue	- -	- -	1	- -	2	6	12	10	4	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc ST Liabilities	- -	1	2	3	3	4	6	6	9	7
Total Current Liabilities	1	8	10	12	20	24	29	32	31	37
+ LT Debt	- -	- -	- -	- -	- -	25	64	63	62	53
+ LT Borrowings	- -	- -	- -	- -	- -	- -	40	40	41	35
+ LT Finance Leases	- -	- -	- -	- -	- -	25	25	23	21	19
+ Other LT Liabilities	- -	1	1	1	9	23	30	3	24	62
+ Accrued Liabilities	- -	1	1	1	9	23	10	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Liabilities	- -	- -	- -	- -	- -	- -	20	3	24	62
Total Noncurrent Liabilities	- -	2	1	1	9	47	94	66	86	115
Total Liabilities	1	10	11	13	28	71	123	98	117	152
+ Preferred Equity and Hybrid Capital	82	82	- -	- -	- -	- -	- -	- -	- -	- -
+ Share Capital & APIC	2	6	182	221	296	372	468	549	686	739
+ Common Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Additional Paid in Capital	2	6	182	221	296	372	468	549	686	739
- Treasury Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Retained Earnings	-24	-54	-101	-155	-218	-293	-377	-464	-558	-723
+ Other Equity	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Equity Before Minority Interest	60	34	81	65	79	79	91	85	128	17
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Equity	60	34	81	65	79	79	91	85	128	17
Total Liabilities & Equity	61	44	91	78	107	150	213	183	244	168
Shares Outstanding	2	2	2	3	3	4	6	6	20	26
Number of Employees	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Capital Leases - Total	- -	- -	- -	- -	- -	26	27	25	23	21
Net Debt	-60	-36	-59	-32	-50	-41	-134	-52	-127	-98
Net Debt to Equity	-100.25	-105.46	-72.69	-49.3	-63.48	-52.34	-148.46	-61.07	-99.28	-589.98
Tangible Common Equity Ratio	-35.41	-109.93	88.26	83.23	73.61	52.8	42.46	46.58	52.25	9.91
Current Ratio	48.36	4.58	8.94	5.89	5.21	4.87	6.24	4.33	6.87	3.95
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Cash Flow Statement (USD)

API Chat

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
+ Net Income	-13	-30	-48	-54	-62	-75	-84	-87	-95	-165
+ Depreciation & Amortization	- -	1	1	2	2	3	3	3	3	2
+ Non-Cash Items	1	3	4	4	6	16	14	-5	-26	48
+ Stock-Based Compensation	1	3	4	4	7	10	11	10	11	10
+ Deferred Income Taxes	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -	- -	- -	- -	- -	- -	1
+ Other Non-Cash Adj	- -	- -	- -	- -	-1	6	3	-16	-37	37
+ Chg in Non-Cash Work Cap	- -	3	2	3	14	-3	10	-11	-6	5
+ (Inc) Dec in Accts Receiv	- -	- -	- -	1	- -	-20	18	-1	1	2
+ (Inc) Dec in Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	- -	-1	- -	- -	-1	- -	-1	-3	2
+ Inc (Dec) in Accts Payable	- -	4	3	4	5	-2	- -	5	5	3
+ Inc (Dec) in Other	- -	- -	-1	-1	10	20	-8	-14	-9	-2
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Operating Activities	-12	-23	-41	-45	-40	-60	-57	-100	-123	-110
+ Change in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -	2
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	2
+ Disp of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	-1	-2	-1	-1	-13	-3	-1	-1	- -
+ Acq of Fixed Prod Assets	- -	-1	-2	-1	-1	-13	-3	-1	-1	- -
+ Acq of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	50	32	69	61	102	70	120	43
+ Increase in Capital Stock	- -	- -	50	32	69	61	102	70	120	43
+ Decrease in Capital Stock	- -	-1	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	-25	-15	-9	1	50	-51	68	36
+ Dec in LT Investment	- -	- -	- -	27	88	109	50	- -	68	87
+ Inc in LT Investment	- -	- -	-25	-42	-97	-108	- -	-51	- -	-51
+ Net Cash From Acq & Div	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Investing Activities	- -	-1	-27	-16	-11	-12	47	-53	67	37
+ Dividends Paid	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Cash From Debt	- -	- -	- -	- -	- -	- -	39	- -	- -	- -
+ Cash From Debt	- -	- -	- -	- -	- -	- -	40	- -	- -	- -
+ Repayments of Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Financing Activities	69	- -	40	2	1	5	1	- -	12	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Financing Activities	69	- -	91	34	69	66	143	71	131	43
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Changes in Cash	57	-24	23	-26	18	-6	132	-82	75	-29
EBITDA	-13	-29	-47	-53	-63	-75	-79	-96	-124	-124
EBITDA Margin (%)	- -	-9,217.03	-14,728.71	-4,828.25	-3,058.15	-3,785.02	-525.16	-410.43	-831.03	-1,250.47
Free Cash Flow	-12	-24	-43	-46	-42	-73	-61	-101	-124	-110
Net Cash Paid for Acquisitions	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-29	-129	-46	-42	-73	-21	-101	-125	-108
Free Cash Flow per Basic Share	-49.16	-97.78	-33.76	-17.93	-12.77	-18.12	-13.18	-16.12	-9.84	-3.88
Price/Free Cash Flow	- -	- -	-4.04	-5.63	-4.67	-5.84	-9.25	-2.07	-0.37	-2.02
Cash Flow to Net Income	0.89	0.77	0.85	0.83	0.65	0.8	0.68	1.15	1.3	0.67
Capital Expenditures	- -	-1	-2	-1	-1	-13	-3	-1	-1	- -